Life cycle assessment of pharmaceuticals: the ciprofloxacin hydrochloride case
- PDF / 1,768,108 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 26 Downloads / 199 Views
LCA AND CHEMISTRY
Life cycle assessment of pharmaceuticals: the ciprofloxacin hydrochloride case Kexuan Yang1 · Bihong Lv1 · Huazhen Shen1 · Guohua Jing1 · Zuoming Zhou1 Received: 17 June 2019 / Accepted: 10 November 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Purpose Despite the benefits in human health from pharmaceuticals, their production has simultaneously given rise to severe environmental pollution. Using ciprofloxacin hydrochloride production as an example, the objectives of this study were to determine the key materials and stages in the life cycle of pharmaceutical production and to develop methods to prevent high materials/energy consumption and pollution. Methods The environmental impacts were evaluated by the Eco-indicator 99 (EI 99) method built into the Ecoinvent database of the Simapro software. The functional unit was set to the annual production of 280 million ciprofloxacin hydrochloridet tablets. The data in this study regarding the process parameters, raw materials energy consumption, and the emissions of pollutants were provided by a pharmaceutical enterprise located in the Zhejiang province, China. The complete production process was classified into three stages, active pharmaceutical ingredient (API) synthesis, galenic formulation, and packaging following the product category rules (PCR) for pharmaceuticals. Results and discussion API synthesis had the largest environmental contribution, followed by galenic formulation, and packaging, which accounted for 42.9%, 41.9%, and 15.2%, respectively. The most important influencing factors of the first two stages were polyols which represent solvents or reaction media used and electricity (coal-fired generation). The damage categories of both factors were ranked from high to low as follows: human health, resources, and ecosystems. The ecological index points of human health in the API synthesis decreased by 8 k point (kPt) after solvent replacement, by 4 kPt after coal-based electricity generation was replaced with natural gas, and by 12 kPt after simultaneous optimization. Conclusions The proposed improvements for cleaner production all proved the feasibility of environmental sustainability in pharmaceutical production. Compared with energy optimization, the solvent replacement was a more effective and convenient method to reduce the environmental impact of ciprofloxacin hydrochloride production. Keywords Pharmaceuticals · PCR · Solvent replacement · Energy optimization
1 Introduction As pharmaceutical production emerges as a rapidly expanding global market, it faces new challenges in controlling and preventing environmental pollution (Rosenthal and Lutz, 2018; Thiebault et al. 2017). To achieve current sustainability goals, strategies such as energy efficiency maximization, Communicated by Matthias Finkbeiner. * Bihong Lv [email protected] 1
Department of Environmental Science & Engineering, College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian, China
carbon footprint reduction, an
Data Loading...
